Photo of Kevin M. Zielke

Kevin M. Zielke Member

Kevin M. Zielke is the Leader of the Pharmaceutical Team and a former Practice Group Leader for Dykema's Pharmaceutical and Medical Device Litigation Practice Group. He is a litigator based in the Firm's Detroit office. In his work for pharmaceutical and medical device manufacturers, Mr. Zielke combines a thorough understanding of the medical and scientific issues with his exceptional legal judgment to develop proactive and creative steps to anticipate, avoid and minimize the potential impact of litigation. Should litigation ensue, these skills allow Mr. Zielke to provide clients with the best factual and scientific defense. This experience has put Mr. Zielke at that critical point where the science, the facts, the regulatory environment and the company conduct intersect and the interplay of these elements must be carefully considered in formulating the most effective strategy.


  • Gadolinium Based Contrast Agents LitigationRepresent Bayer in litigation regarding its gadolinium-based contrast agent, Magnevist® (gadopentetate dimeglumine). Member of national science and expert teams.
  • Trasylol Litigation. Represent Bayer in litigation regarding its cardiac surgery drug, Trasylol® (aprotinin injection). Member of national science and expert teams.
  • Phenylpropanolamine (PPA) Litigation. Represented Bayer in litigation regarding the use of PPA in its over-the-counter cough/cold treatment, Alka Seltzer Plus®. Member of national science and expert teams.
  • Imitrex Litigation. Represented GlaxoWellcome in litigation regarding Imitrex® (sumatriptan succinate), a drug indicated for the acute treatment of migraine attacks with or without aura and cluster headache episodes.

Memberships & Involvement

  • State Bar of Michigan, Member
  • American Bar Association, Member
  • Detroit Metropolitan Bar Association